[HTML][HTML] Cancer-related alopecia: From etiologies to global management

S Quesada, A Guichard, F Fiteni - Cancers, 2021 - mdpi.com
Simple Summary Although it does not represent a condition that threatens the life of patients,
alopecia nevertheless has an essential impact on the quality of life of patients, particularly in …

Pharmacogenetics of breast cancer treatments: a sub-Saharan Africa perspective

KC Nthontho, AK Ndlovu, K Sharma… - Pharmacogenomics …, 2022 - Taylor & Francis
Breast cancer is the most frequent cause of cancer death in low-and middle-income
countries, in particular among sub-Saharan African women, where response to available …

Clinicopathologic characteristics and response to treatment of persistent chemotherapy-induced alopecia in breast cancer survivors

B Bhoyrul, L Asfour, G Lutz, L Mitchell… - JAMA …, 2021 - jamanetwork.com
Importance Alopecia induced by classic chemotherapy affects up to 65% of patients and is
usually reversible. However, there are increasing reports of persistent chemotherapy …

[HTML][HTML] Anagen effluvium

D Saleh, A Nassereddin, C Cook - 2018 - europepmc.org
Objectives: Identify the etiology of anagen effluvium. Describe the history and physical exam
findings typically seen in patients with anagen effluvium. Outline the management options …

[HTML][HTML] Алопеция в онкологии: практическое значение фундаментальных исследований

ИВ Станоевич, ВВ Хвостовой, ЕИ Тишина… - Сибирский …, 2023 - cyberleninka.ru
Цель исследования-отразить современное представление о частоте, молекулярных
механизмах, средствах преодоления алопеции у онкологических пациентов с учетом …

Alopecia in oncology: the practical significance of fundamental research

IV Stanoevich, VV Khvostovoy, EI Tishina… - Siberian journal of …, 2023 - siboncoj.ru
Purpose. To reflect the current understanding of the frequency, molecular mechanisms, and
means of overcoming alopecia in cancer patients, taking into account the fundamental data …

Drug-Induced Scarring and Permanent Alopecia

S Perez, B Nguyen, A Tosti - JAAD Reviews, 2024 - Elsevier
Permanent drug-induced alopecia is rare; however, increasing cases are being reported.
Non-inflammatory phenotypes include permanent/persistent alopecia after chemotherapy …

Alopécie et cancers: de la physiopathologie à la pratique clinique

S Quesada, A Guichard, S Le Vigouroux, L Baussard… - Bulletin du …, 2021 - Elsevier
Résumé L'alopécie, bien que longtemps considérée comme une conséquence inévitable de
la thérapeutique anticancéreuse, représente actuellement un défi aux multiples facettes. La …

Why Do Not All Chemotherapy Patients Lose Their Hair? Answering an Intriguing Question

A Rebora, M Guarrera - Skin Appendage Disorders, 2021 - karger.com
Alopecia is one of the side effects of chemotherapy that patients fear most; to the point that,
just for that reason, up to 14% of women refuse chemotherapy. In fact, chemotherapy drugs …

Insights Into the Biology of Persistent Chemotherapy-Induced Alopecia via Genomic Approaches—An Avenue to Clinical Translation?

FB Basmanav, MM Nöthen, RC Betz - JAMA dermatology, 2020 - jamanetwork.com
A major concern among patients with cancer is hair loss secondary to chemotherapy, an
adverse effect that occurs among approximately 65% of patients who undergo this form of …